TY  - GEN
AU  - Chanthavanich,Pornthep
AU  - Anderson,Edwin
AU  - Kerdpanich,Phirangkul
AU  - Bulitta,Michael
AU  - Kanesa-Thasan,Niranjan
AU  - Hohenboken,Matthew
TI  - Safety, Tolerability and Immunogenicity of an MF59-adjuvanted, Cell Culture-derived, A/H5N1, Subunit Influenza Virus Vaccine: Results From a Dose-finding Clinical Trial in Healthy Pediatric Subjects
SN  - 1532-0987
PY  - 2020///0422
KW  - Adjuvants, Immunologic
KW  - administration & dosage
KW  - Adolescent
KW  - Antibodies, Viral
KW  - blood
KW  - Child
KW  - Child, Preschool
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - epidemiology
KW  - Female
KW  - Healthy Volunteers
KW  - Hemagglutination Inhibition Tests
KW  - Humans
KW  - Infant
KW  - Influenza A Virus, H5N1 Subtype
KW  - immunology
KW  - Influenza Vaccines
KW  - Influenza, Human
KW  - prevention & control
KW  - Male
KW  - Polysorbates
KW  - Single-Blind Method
KW  - Squalene
KW  - United States
KW  - Vaccines, Subunit
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1097/INF.0000000000002345
ER  -